Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
Stopped early · Phase 3
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The primary objective of this extension study (GS-US-312-0117) that is a companion study to Study GS-US-312-0116 (NCT01539512), is to evaluate the effect of idelalisib on the onset, magnitude, and duration of tumor control. Randomization was done in study GS-US-312-0116, and carried forward to study GS-US-312-117.
Key facts
- Study ID
- NCT01539291
- Run by
- Gilead Sciences
- People needed
- 161
- Starts
- 2012-10-03
- Expected to finish
- 2018-06-29
- Last updated by the study team
- 2019-08-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clearview Cancer Institute — Huntsville, Alabama, United States
- Arizona Oncology Associates — Tucson, Arizona, United States
- University of California, San Diego - Moores Cancer Center — La Jolla, California, United States
- Ventura County Hematology Oncology Specialists — Oxnard, California, United States
- UCLA — Santa Monica, California, United States
- Stanford Cancer Center — Stanford, California, United States
- Rocky Mountain Blood and Marrow Transplant Program — Denver, Colorado, United States
- Rocky Mountain Cancer Center — Denver, Colorado, United States
- Georgetown University Medical Center Lombardi Cancer Center — Washington D.C., District of Columbia, United States
- Collaborative Research Group — Boynton Beach, Florida, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- Florida Cancer Specialists — St. Petersburg, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Hackensack University Medical Center — Hackensack, New Jersey, United States
- Long Island Jewish Medical Center — New Hyde Park, New York, United States
- Weill Cornell Medical College — New York, New York, United States
- Columbia University Medical Center — New York, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Willamette Valley Cancer Center — Springfield, Oregon, United States
- Northwest Cancer Specialists, PC — Tualatin, Oregon, United States
- Cancer Centers of the Carolinas — Greenville, South Carolina, United States
- Sarah Cannon Research Institute — Nashville, Tennessee, United States
- Texas Oncology, P.A. — Fort Worth, Texas, United States
- M.D. Anderson Cancer Center — Houston, Texas, United States
- Cancer Care Network of South Texas — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.